Mesenchymal Stem Cell Therapy for Doxorubicin-Induced Cardiomyopathy: Potential Mechanisms, Governing Factors, and Implications of the Heart Stem Cell Debate

Overview of attention for article published in Frontiers in Pharmacology, June 2019

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (66th percentile)
Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

twitter: 6 X users

Citations

dimensions_citation: 33 Dimensions

Readers on

mendeley: 44 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 6 X posts from 6 X users, with an upper bound of 13,802 followers.

RT @Shoukmed: Do stem cells exist in the adult heart? Do mesenchymal stem cells have a therapeutic value in doxorubicin-induced cardiomyo…

06 May 2020

Reply Repost Favourite

RT @Shoukmed: Do stem cells exist in the adult heart? Do mesenchymal stem cells have a therapeutic value in doxorubicin-induced cardiomyo…

06 May 2020

Reply Repost Favourite

Do stem cells exist in the adult heart? Do mesenchymal stem cells have a therapeutic value in doxorubicin-induced cardiomyopathy? Read more about the answers to these questions in our previous review in @FrontPharmacol. https://t.co/bIiUKySBG3 https:

06 May 2020

Reply Repost Favourite

Does mesenchymal stem cells have a role in DOX cardiomyopathy? Read our recent review in Frontiers of Pharmacology! https://t.co/bIiUKySBG3 #Heart_StemCell_Debate #Move_forward

06 Nov 2019

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.